Back to Results
First PageMeta Content



Final Analysis of a Phase 2 Study of an Autologous Dendritic Cell Immunotherapy (AGS-004) Showed Positive Outcomes in Primary Endpoint of Viral Load Control, and Favorable Safety and Immunogenicity Profile, in Subjects U
Add to Reading List

Document Date: 2013-12-05 12:55:45


Open Document

File Size: 436,86 KB

Share Result on Facebook